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ABSTRACT 
This study aimed for the synthesis of 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 suitable for use 
as antibacterial, anti-oxidant and anti-inflammatory activities via a versatile, readily accessible 3-((2E)-3(aryl)prop-2-enoyl)-
2H-chromen-2-one 3  which  was prepared by refluxing 3-acetyl-4-hydroxycoumarin with aromatic aldehydes in chloroform 
in the presence of a catalytic amount of piperidine. Then the direct reaction of the obtained chalcones 3 with malonitrile in 
the presence of ammonium acetate in one step gave products 5 The structures of the new compounds 3-4 were confirmed 
by elemental analysis, IR, and multinuclear/multidimensional NMR spectroscopy (
1
H, 
13
C-NMR, NOESY, HMBC) which 
allowed assignment of the complete network of proton and carbon atoms. Most of the new compounds 4 exhibit 
moderate antibacterial activity against Gram Negative bacterial strains (E. coli, K. pneumonia, S. typhi and S. flexneri). In 
addition, the compounds 4 were investigated for anti-oxidant activities by super oxide radical, DPPH (2,2-Diphenyl-1-
picrylhydrazyl), and hydroxyl radical scavenging assays, where most of the compounds displayed significant antioxidant 
activities. Furthermore, these 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 were evaluated for 
anti-inflammatory activity by indirect haemolytic and lipoxygenase inhibition assays where compounds revealed good 
activity. 
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1. INTRODUCTION 
The synthesis of 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles  derivatives 4 has attracted 
considerable attention of organic and medicinal chemists due to its wide usage in the field of drugs and pharmaceuticals 
with diverse biological activities like anticoagulant [1 ], antihypertensive [2], anti-inflammatory [3], antipsychotic [4], 
antidiabetic [5], antihelminthic [6] and antimicrobial activities [7, 8]. Nowadays various bacteria are found to resist classical 
antimicrobial agents [9]. Also, free radicals are highly reactive species generated endogenously with the involvement of 
oxygen in normal metabolic conditions and lack of antioxidant capacity of an organism may result in cancer development 
[10]. Besides, pathogen invasion, injuries and manifestation to chemicals results in inflammation which may leads to 
cancer, allergy, Alzheimer‟s disease, rheumatoid arthritis and diabetes mellitus [11].  
Based on the literature survey on the pharmacological properties [12], we aimed to synthesize and characterize new 4-
Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles incorporating coumarin moiety. The chemical structures 
of the synthesized compounds 4 were determined by spectroscopic techniques. Their antibacterial, antioxidant activities 
and anti inflammaratory anti-inflammatory activity by indirect haemolytic and lipoxygenase were investigated. 
2. EXPERIMENTAL 
1. General 
Reactions were monitored by thin layer chromatography (TLC) using precoated sheets of silica gel G/UV-254 of 0.25 mm 
thickness (Merck 60F254). The melting points were measured in Selaco melting point apparatus in an open capillary and 
are uncorrected.  Elemental analysis (C, H, N) was performed using the CE-400 CHN elemental analyzer. Infrared spectra 
were recorded on Shimadzu FT-IR model 8300 spectrophotometer using KBr method.
 1
H NMR spectra were recorded 
using Brucker 400 NMR spectrometer operating at 400 MHz using TMS as the internal standard and CDCl3 as a solvent. 
Mass spectra were obtained using Agilant mass spectrometer in ESI mode. All chemicals were obtained from Aldrich, 
Fluka and Merck Chemicals. 
2. Acetyl-4-hydroxycoumarin 2 
To a solution of 4-hydroxy-2H-chromen-2-one (3.0 g, 1.86mmol) in acetic acid (16 ml) phosphorus oxychloride (5.6 ml) 
was added. The mixture was heated at reflux for 30 min. After cooling to room temperature, the precipitate which 
separated out was collected by filtration and recrystallized from ethanol to give 3-acetyl-4-hydroxy-2H-chromen-2-one as 
white needles. Yield 2.7 g (90%);Mp = 135 °C. IR spectrum, ν cm
–1
: 3185 (OH); 1705 (CO);1700 (O–CO lactone). 
1
H NMR 
spectrum (CDCl3) δ:2.72 (3H, s, CH3); 7.98 (1H, s, H-5); 7.95 (1H, dd, 
3
J 7.8,  8.35, 
4
J 6.8, 1.2 Hz, H-8); 7.1–7.4 (2H, m, 
H-6 + H-7); 17.7 (1H, s, OH).
13
C{
1
H} NMR spectrum (CDCl3): δ: 29.9 (CH3); 178.5 (CO);159.8 (C-4); 154.6 (C-2); 101.3 
(C-3); 115.0–136.0 (Carom). 
3. General procedure for the preparation of the coumarinic chalcones 3a–e 
3-Acetyl-4-hydroxy-2H -chromen-2-one (0.031 mol) and the substituted aromatic aldehyde (0.03 mol) were dissolved in 30 
mL of chloroform. A catalytic amount of piperidine (0.02 mol) was added and the reaction mixture was refluxed for 1.5 h. 
The chloroform was removed under vacuum and the residue was washed with methanol 
3-((2E)-3(Phenyl)prop-2-enoyl)-2H-chromen-2-one: 3a 
Yield 85 Yiled 85%; mp 265 ºC. IR spectrum, ν cm
–1
: 1490 (C=O), 1728 (O-C-O), 1529 (C=C). 
1
H NMR spectrum (CDCl3) 
δ ppm: 6.5-8.3 (m,11H,Harom,Heth);  18.25 (s,1H,OH). 
13
C NMR spectrum (CDCl3): δ ppm  116. 9 (C3); 135.8 (C2); 
147.1(C4); 134.7 (Cethyl); 180.6 (CO); 135.9(Céthyl 1); 131.4(Céthyl 2); 126. 9 (C5); 125. 4 (C6); 128. 3 (C7); 128. 3 (C8); 135. 
1 (C9); 126. 3 (C10); 128. 6 (C11); 127. 9 (C12); 128. 7 (C13); 126. 3 (C14). 
3-((2E)-3(4-Fluorophenyl)prop-2-enoyl)-2H-chromen-2-one: 3b 
Yiled 80%;  mp 255ºC. IR spectrum, ν cm
–1
: 1494 (C=O), 1716 (O-C-O), 1531 (C=C). 
1
H NMR spectrum (CDCl3, 400MHz) 
δ ppm: 6.51-8,21(m, 10H, Harom+éthyl ); 18. 4 (s, 1H, OH). 
13
C NMR spectrum (CDCl3) δ ppm:  100.9 (C3); 154.8 (C2); 166.0 
(C4); 181.5 (CO); 136.2(Céthyl 1); 131.5(Céthyl 2);126. 8 (C5); 125. 3 (C6); 128. 4 (C7); 129. 3 (C8); 135. 2 (C9); 126. 5 (C10); 
128. 7 (C11); 127. 8 (C12); 128. 6 (C13); 126. 4 (C14). NMR 
19
F (CDCl3, 400 MHz, tamb)   ppm: -107,8 
 3-((2E)-3(2, 5-Dimethylphenyl) prop-2-enoyl)-2H-chromen-2-one: 3c 
Yield 75 %; mp 224ºC. IR spectrum, ν cm
–1
: 1490 (C=O), 1720 (O-C-O), 1527 (C=C). 
1
H NMR spectrum (CDCl3,400 MHz) 
δ ppm: 2,41 (s,1H,CH3),3,21 (s,3H,CH3), 6,82-8,21 (m,9H,Harom+éthy);13.81 (s,1H,OH). 
13
C NMR spectrum (CDCl3): δ  ppm:  
91. 4 (C3); 135.8 (C2); 161.4 (C4); 139;1 (Céthyl), 134.1 (Céthy2); 126. 7 (C5); 125. 4 (C6); 128. 3 (C7); 128. 9 (C8); 135. 4 
(C9); 126. 4 (C10); 127. 8 (C11); 127. 7 (C12); 128. 5 (C13); 126. 3(C14); 176.2 (CO). 
 3-((2E)-3(4-Methoxyphenyl) prop-2-enoyl)-2H-chromen-2-one: 3d 
Yield 75 %; mp 194ºC. IR spectrum, ν cm
–1
: 1494 (C=O), 1708 (O-C-O), 1595 (C=C). 
1
H NMR spectrum (CDCl3): δ ppm 
3.84(s,3H,OCH3); 6.92 (d,1H,CH); 8.25 (d,1H,CH); 7.25-8.08 (m,8H,Harom); 18.05(s,1H,OH). 
13
C NMR spectrum (CDCl3): δ 
ppm  55.4 (OCH3); 114.4 (C3); 126. 8 (C5); 125. 2 (C6); 127. 9 (C7); 128. 8 (C8); 134. 8 (C9); 126. 3 (C10); 127. 7 (C11); 
127. 5 (C12); 128. 4 (C13); 126. 2(C14); 135.6 (C2); 147.5 (C4); 162.4 (CO). 
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3-((2E)-3(4-Methoxyphenyl) prop-2-enoyl)-2H-chromen-2-one: 3e 
Yield 75 %; mp 194ºC. IR spectrum, ν cm
–1
: 1494 (C=O), 1708 (O-C-O), 1595 (C=C). 
1
H NMR spectrum (CDCl3): δ ppm 
3.84(s,3H,OCH3); 6.92 (d,1H,CH); 8.25 (d,1H,CH); 7.25-8.08 (m,8H,Harom); 18.05(s,1H,OH). 
13
C NMR spectrum (CDCl3): δ 
ppm  55.4 (OCH3); 114.4 (C3); 126. 8 (C5); 125. 2 (C6); 127. 9 (C7); 128. 8 (C8); 134. 8 (C9); 126. 3 (C10); 127. 7 (C11); 
127. 5 (C12); 128. 4 (C13); 126. 2(C14); 135.6 (C2); 147.5 (C4); 162.4 (CO). 
 3-((2E)-3(4-tollyl)prop-2-enoyl)-2H-chromen-2-one: 3f 
Yield 72 %; mp 185ºC. IR spectrum, ν cm
–1
: 1490 (C=O), 1715 (O-C-O), 1540 (C=C). 
1
H NMR spectrum (CDCl3) δ ppm: 
2.1(s,3H,CH3),7.1-8.6 (m,1OH, Harom+ethyl); 18.4 (s, 1H,OH). 
13
C NMR spectrum (CDCl3): δ ppm:22.6(CH3),  98.7 (C3); 
151.8 (C2); 178.7 (C4); 182.5 (CO); 151.9(Cethyl 1); 122.5(Cethyl 2); 126. 7 (C5); 125. 3 (C6); 127. 8 (C7); 128. 7 (C8); 135. 2 
(C9); 126. 4 (C10); 127. 6 (C11); 127. 4 (C12); 128. 5 (C13); 126. 3(C14). 
4. General procedures for the preparation of 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-
yl) pyridine-3-carbonitriles derivative 4 
To a mixture of coumarinic chalcones 3a–e ( 1g, 5 mmol) in ethyl alcohol ( 20mL), malonitrile (0.33g, 5 mmol) and 
ammonium acetate (0.75g, 10 mmol)  were added. The reaction mixture was refluxed for 7-9h. The obtained solid was 
filtered off, washed with absolute ethylalcohol and recrystallized from methyl alcohol to give the desired compounds  
4-phenyl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4a 
Yield 86 %; mp 265 ºC. IR spectrum, ν cm
–1
: 3264 (OH, br s), 3043 (NH), 2364 (CN), 1697 (C=O, a-pyrone), 1612 
(C=O).1643 (C=N). 
1
H NMR spectrum (CDCl3) δ ppm: 6.3-8.6 (m,10H,Harom,H2‟); 4.81 (s,2H,NH2) ,18.25 (s,1H,OH). 
13
C 
NMR spectrum (CDCl3): δ ppm 56.1(OCH3), 97.6 (C3); 109.5 (C4‟); 122.6(C2‟); 151.9 (C3‟); 153.7 (C5‟), 162.1 (C2), 168.2 
(C4), 114.1-129.5(Carom+ Ccoumarinic), 160.4 (C1‟). Anal. Calcd for C22H15O3N3: C, 71.536%; H, 4.093%, N, 11.376%, 
Found: C, 71.4%; H,4.093%,N, 11.3 %, 
4-fluorophenyl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4b 
Yield 80 %; mp 265 ºC. IR spectrum, ν cm
–1
: 3430 (OH, br s), 3187 (NH), 1675 (C=O, a-pyrone), 1603 (C=N).. 
1
H NMR 
spectrum (CDCl3) δ ppm: 6.2-8.3 (m,9H,Harom,H2‟);  4.81 (s,2H,NH2),18.25 (s,1H,OH). 
13
C NMR spectrum (CDCl3): δ ppm 
56.1(OCH3), 97.6 (C3); 109.5 (C4‟); 122.6(C2‟); 151.9 (C3‟); 153.7 (C5‟), 162.1 (C2), 168.2 (C4), 114.1-129.5(Carom+ 
Ccoumarinic), 160.4 (C1‟). Anal. Calcd for C21H12O3N3F: C, 67.560%; H, 3.240%, N, 11.255%, F, 5.089% Found: C, 67.4%; 
H, 3.10%, N, 11.2% 
4-2.5-phenyl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4c 
Yield 85 %; mp 265 ºC. IR spectrum, ν cm
–1
: 3262 (OH, br s), 3098 (NH), 2354 (CN), 1696 (C=O, a-pyrone), 1658 (C=O). 
1
H NMR spectrum (CDCl3) δ ppm: 6.4-8.2 (m,8H,Harom,H2‟); 4.81 (s,2H,NH2), 2.1(s,CH3), 2.3(s,CH3) 18.25 (s,1H,OH). 
13
C 
NMR spectrum (CDCl3): δ ppm 56.1(OCH3), 97.6 (C3); 109.5 (C4‟); 122.6(C2‟); 151.9 (C3‟); 153.7 (C5‟), 162.1 (C2), 168.2 
(C4), 114.1-129.5(Carom+ Ccoumarinic), 160.4 (C1‟). Anal. Calcd for C23H17O3N3: C, 72.052%; H, 4.469%, N, 10.960%, 
Found: C, 72.1%; H, 4.4%, N, 10.9% 
4-Anisyl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4d 
Yield 80 %; mp 265 ºC. IR spectrum, ν cm
–1
: 3316 (OH, br s), 3208, 3057 (NH2), 2206 (CN), 1680 (C=O, α-pyrone), 1643 
(C=N). 
1
H NMR spectrum (CDCl3) δ ppm: 3.75(s, 3H, OCH3), 6.4-8.2 (m,12H,Harom,H2‟); 4.81 (s,2H,NH2), 18.25 (s,1H,OH). 
13
C NMR spectrum (CDCl3): δ ppm 56.1(OCH3), 97.6 (C3); 109.5 (C4‟); 122.6(C2‟); 151.9 (C3‟); 153.7 (C5‟), 162.1 (C2), 
168.2 (C4), 114.1-129.5(Carom+ Ccoumarinic), 160.4 (C1‟). Anal. Calcd for C21H13O3N3: C, 70.980% ; H, 3.687%, N, 
11.825%, Found: C, 70.9%; H, 3.6%, N, 11.8%, 
4-nitrophenyl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4e 
Yield 85 %; mp 265 ºC. IR spectrum, ν cm
–1
: 3392 (OH, br s), 3118, 3099 (NH2), 2210 (CN), 1722 (C=O, α-pyrone), 1653 
(C=N). 
1
H NMR spectrum (CDCl3) δ ppm: 6.5-8.3 (m,9H,Harom,H2‟);  18.25 (s,1H,OH), 4.81 (s,2H,NH2). 
13
C NMR spectrum 
(CDCl3): δ ppm 56.1(OCH3), 97.6 (C3); 109.5 (C4‟); 122.6(C2‟); 151.9 (C3‟); 153.7 (C5‟), 162.1 (C2), 168.2 (C4), 114.1-
129.5(Carom+ Ccoumarinic), 160.4 (C1‟). Anal. Calcd for C22H15O4N3: C, 68.566% ; H, 3.923, N, 10.904%, Found: C, , 
68.5%; H, 3.9%, N, 10.9% 
4-tollyl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4f 
Yield 75 %; mp 265 ºC. IR spectrum, ν cm
–1
: 3449 (OH, br s), 3057(NH), 2739 (CN), 1739 (C=O, a-pyrone), 1692 (C=O). 
1
H NMR spectrum (CDCl3) δ ppm: 6.4-8.2 (m,12H,Harom,H2‟); à,2.1(s,CH3),  18.25 (s,1H,OH). 
13
C NMR spectrum (CDCl3): 
δ ppm 56.1(OCH3), 97.6 (C3); 109.5 (C4‟); 122.6(C2‟); 151.9 (C3‟); 153.7 (C5‟), 162.1 (C2), 168.2 (C4), 114.1-129.5(Carom+ 
Ccoumarinic), 160.4 (C1‟). Anal. Calcd for C23H17O3N3: C, 72.052%; H, 4.469%, N, 10.960%, Found: C, 72.1%; H, 4.4%, N, 
10.9%. 
All 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles derivative 4 derivatives were evaluated for their 
antibacterial activity against four human pathogenic bacterial strains. These include Escherichia coli (MTCC 40), Klebsiella 
pneumoniae (MTCC 661), Salmonella typhi (MTCC 733) and Shigella flexneri (MTCC 1457).  
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The nutrient agar was prepared and sterilized by autoclave. The sterile nutrient agar is cooled to 40
0
C, poured to the 
sterile petriplate and allowed to solidify. The nutrient agar was then inoculated with 10
6 
cfu/mL of respective 
microorganism using sterile spreader. Wells are made using sterile cork borer (8.5 mm) and compounds to be tested are 
added to each well with different concentrations ranging from 10 to 1000 μg/mL. These were made from the stock solution 
of 4 mg/mL in dimethyl sulfoxide (DMSO). A 100 μL volume of each dilution was introduced into wells (in duplicates) in the 
agar plates already seeded with bacterial suspension. These plates were incubated at 37°C for 24 h and observed for 
inhibition zones. Gentamicin was used as positive control. 
Antioxidant activity 
DPPH radical scavenging assay: The free radical scavenging activity for DPPH radicals wasperformed as 
described previously [22]. In brief, reaction mixture containing 200 µL of 0.1 mM DPPH–ethanol solution, 90 µL of 50 mM 
Tris–HCl buffer (pH 7.4) and 10 µL of deionised water (as control) and various concentrations of compounds 4-a-f (3.0 – 
16.0 µM), and ascorbic acid was used as a control. Reaction mixture was incubated for 30 min at room temperature and 
absorbance was read at 540 nm. The percentage radical scavenging activity was calculated according to the following 
formula: Inhibition (%) = [(Absorbance control-Absorbance sample)/Absorbance Control] X 100         
Hydroxyl radical scavenging assay: The hydroxyl radical (
.
OH) scavenging activity of newly synthesized compounds 
was determined previously [23]. We used Fe (III) - ascorbate – ethylenediaminetetraacetic acid – hydrogen peroxide 
system (Fenton‟ s reaction) to generate hydroxyl radical. In brief, reaction mixture containing 0.01 mL of FeCl3 (10 mM), 
0.1 mL of EDTA (1 mM),0.36 mL of deoxyribose (10 mM), 0.1 ml of H2O2 (10 mM), 1 mL of the compounds 4a-
f(concentrations ranging from 3.0 – 16 .0 µM), 0.33 mL of phosphate buffer (50 mM, pH 7.4) and 0.1 mL ascorbic acid (1 
mM) was added. The mixture was incubated at 37
0
C for 1 h and 1 mL of the incubated mixture was mixed with 1 mL of 
10% trichloro acetic acid (TCA) and 1mL of thiobarbituric acid (TBA) (1% in 0.025 M NaOH), the resulting mixture was 
incubated in water bath at 90
0
C for 20 min. The absorbance was measured at 532 nm. Ascorbic acid was used as a 
positive control. The percentage of hydroxyl radical scavenging activity was calculated using the formula: Inhibition (%) = 
[(Absorbance control-Absorbance sample)/Absorbance Control] X 100         
Superoxide anion radical scavenging assay: The superoxide anion radical scavenging activity of newly synthesized 
compounds were determined previously [24]. 1 mL of Nicotinamide adenine dinucleotide (NADH) (468 µM in 100 mM 
phosphate buffer of pH 7.4), 1 mLofNitro blue tetrazolium (NBT) (156 µM NBT in 100 mM phosphate buffer of pH 7.4), 
and different concentration of compounds 4a-f (3.0– 16.0 µg/mL) were added to get the final volume of 3 mL. The reaction 
was started by the addition of 100 µL of PMS (60 µM in 100 mM phosphate buffer of pH 7.4). The mixture was incubated 
for 5 min at 25
0
C and the absorbance was measured at 560 nm. Quercetin was used as a control. The percentage radical 
scavenging activity was calculated using the formula: Inhibition (%) = [(Absorbance control-Absorbance 
sample)/Absorbance Control] X 100 . 
Anti-inflammatory activity 
Lipoxygenase inhibition assay: The lipoxygenase inhibition assay was performed according to the method previously 
described [25]. Briefly, to a solution of 0.1 mL of 0.2 M borate buffer (pH 9.0), 0.1 mL of 1000 units lipoxydase enzyme 
solution, test compounds 4a- f dissolved in DMSO (3 - 16 μM) was added, agitated and incubated at room temperature for 
5 min. Later, 2.0 mL of 0.6 mM linoleic acid was added and the absorbance was measured at 234 nm. Indomethacin was 
used as standard. The percent (%) inhibition was calculated by the following equation:  
Inhibition (%) = [(Absorbance control-Absorbance sample)/Absorbance Control] X 100         
Indirect haemolytic assay: Indirect haemolytic assay was performed according to the reported method [26]. One mL of 
fresh human red blood cells and 1 mL of fresh Hen‟s egg yolk in 8 mL of phosphate buffered saline was mixed to prepare 
the substrate for indirect hemolytic activity. One mL of this suspension was incubated with 4-28 μg of partially purified 
venom for 45 min at 37
0
C and 9 mL ice cold sodium perborate was used to stop the reaction. The reaction mixture was 
centrifuged at 2000 rpm for 20 min then the released hemoglobin was read at 540 nm. For inhibition studies 10 μg of 
venom sample (secretory- PLA2 purchased from sigma) was incubated with various concentrations of compounds 4a-f 
(20-100 μΜ in DMSO) for 30 min at room temperature and mixed with 1 mL of substrate solution and incubated at room 
temperature for 30 min. The reaction was stopped by adding 9 mL of ice cold sodium perborate and extent of hemolysis is 
measured at 540 nm. Aristolochic acid was used as reference drug. The percent (%) inhibition was calculated as follows: 
Inhibition (%) = [(Absorbance control-Absorbance sample)/Absorbance Control] X 100 .     
3. RESULTS AND DISCUSSION 
In this investigation, a series of 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 were designed, 
synthesized (Schemes 1) and biologically evaluated for their antibacterial , antioxidant activities and anti inflammaratory  
anti-inflammatory activity by indirect haemolytic and lipoxygenase were investigated. Thus, compound 3 was prepared by 
reaction of 4-hydroxycoumarine with POCl3 in chloroform in the presence of acetic acid, The resulting compound 2  was 
then reacted with arylaldehydes in the presence of piperidine at reflux of CHCl3 to give the (E) the coumarinic chalcones 3, 
which precipitated from the hot MeOH solution after mixing 2 with the corresponding ArCHO . Scheme 1 
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O
OH
O O
OH
O
O
O
OH
O
O
i ii
R
i: POCl3, ACOH, ii: CHCl3, piperidine, Arylaldehyde
1 2
3
 
 
Compounds 3 R Yield (%) 
3a H 75 
3b F 80 
3c 2,5 CH3 76 
3d OCH3 85 
3e NO2 75 
3f 3HC  85 
Synthesis of compounds 3 
Compounds 3 were identified from analysis of their spectroscopic data. The infrared (IR) spectrum of compound 3d 
showed the coumarin carbonyl groups at 1768 cm
-1
 in addition to a broad band for the C=C group at 1595 cm
-1
. The 
1
H 
NMR spectrum showed trans olefinic protons Ha and Hb as ortho-coupled doublets at δ 8.25 (J = 15.6 Hz) and 6.92 (J = 
15.9 Hz), respectively. The remaining aromatic protons of the aromatic aldehydes and the four protons of the coumarin 
moiety appeared as a multiplet in the region δ 7.25–8.08. The 
13
C{
1
H} NMR spectrum of 3d in DMSO-d6 showed two 
downfield signals at δ 147.4ppm (C4) and δ 162.4 ppm (lactone C=O) as well as an upfield signal to at δ 55.4 ppm (OCH3).  
The condensation of compounds 3  with malontrile in the presence of ammonium acetate at reflux of EtOH in one step 
afforded  4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 in good yields . Scheme 2  
O
OH
O
O
R
3
CH2(CN)2
CH3COONH4/EtOH/reflux
O
OH
O
N
CN
NH2
Ar
4  
 
 
 
 
 
 
 
 
Scheme 2: Synthesis of 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 
All new 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 were characterized by IR, 1H, 13C-NMR 
spectra as well as by NOESY and HMBC 2D-NMR experiments to elucidate their structures and completely assign the 
structural network of both protons and carbons. The spectral data were in accordance with the proposed structures (see 
Experimental Section). 
The IR spectrum of 4d showed a broad band at 3057 cm
-1
 due to the presence of the NH2 group, a strong band at 3316 
cm
-1
  was attributed for OH. Since chromone carbonyl groups usually appear as sharp absorption bands in the region 
1620–1650 cm
-1
 
27
, the band at 1680 cm
-1
 was assigned to coumarin rather than the chromone carbonyl group. 
Compounds 4 R Yield (%) 
4a H 80 
4b F 75 
4c 2,5 CH3 85 
4d OCH3 75 
4e NO2 70 
4f 3HC  85 
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In addition, the detection of a strong C=N stretching band at 1643 cm
−1
 was indicative of the formation of the pyridine-3-
carbonitriles ring. The 
1
H NMR spectra of 4d displays a signal at δ 3.75 ppm ascribable to the OCH3 protons of the 
pyridine-3-carbonitriles ring. A characteristic singlet proton signal at δ 4.81 ppm was assigned to NH2 protons. In addition, 
the aromatic protons (both coumarinic and aromatic) are observed between δ 6.40 and δ 8.20 ppm . 
In the 
13
C NMR spectrum of 4d indicated carbon atoms at δ 56.1(OCH3), 97.6 (C3); 109.5 (C4‟); 122.6 (C2‟); 151.9 (C3‟); 
153.7 (C5‟), 162.1 (C2), 168.2 (C4), 114.1-129.5 (Carom+ Ccoumarinic), 160.4 (C1‟). 
The structure of 4d was finally elucidated through the analysis of the 
1
H, 
13
C HMBC spectrum which correlates the protons 
at δ 4.81 ppm with C5' (δ 153.07 ppm) and C4 (δ 109.5 ppm). The aromatic protons correlate with C3‟ (δ 151. 9 ppm).  
Table 1 
Correlations between HMBC and NOESY for compound 4d 
Proton 
H-n 
HMBC 
H-n-C-j 
NOESY 
H-n-H-j 
OCH3 9‟, 10', 11' H11‟,H12‟ 
H-5' 5',4'  
H-arom 3',4‟  
OH 4,3,2  
 
Similarly the spectral values for all the compounds and C, H, N analyses are given in the experimental part 
A mechanistic rationalization for this reaction is straightforward and is provided in Scheme 3   
ii
ii: Malonitrile ; ammonium acetate, reflux, 5h
O
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Scheme 3: Proposed mechanism for compound 4 
The first reaction step consists of a nucleophilic attack on the unsaturated carbon, followed by intermolecular cyclization 
follow by a tautomeric enamine amine balance. 
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4. Pharmacology 
Antibacterial activity  
The synthesized 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 a-f  were screened for in 
vitro antibacterial activity against four Gram Negative bacterial strains (E. coli, K. Pnemoniae, S. typhi and S. Flexneri) and 
the results are given in Table 2. All compounds except 4a showed good zone of inhibition against pathogens S. typhi and 
S. flexneri. On the otherhand, all compounds displayed moderate activity against E. coli, but remained poor against K. 
pnemoniae. The compounds 4b,4f with electron withdrawing groups on the phenyl ring showed good antibacterial activity. 
Whereas the compounds 4c and 4f with electron releasing groups on the phenyl ring showed moderate antibacterial 
activity on most of tested bacterial strains and 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 
derivative 4d without substitution on the phenyl ring showed least antibacterial activity. Also, all compounds except 4a 
showed high potency against S. typhi. Thus, deactivating groups on phenyl ring enhances the antimicrobial behaviour of 
4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles derivatives rather than the activating groups.  
 
Table 2 Antibacterial activity of the 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 
derivatives 4a-f 
 
* Inhibition zones including cup borer (8.5 mm) diameter; Positive control zone is 35 to 40 mm; „-‟ = Not active 
 
4. Antioxydant activity  
We considered that it was worthwhile to study the potential aspects of these new 4-Aryl-2-amino-6-(4-hydroxy 
coumarin-3-yl) pyridine-3-carbonitriles 4 derivatives for antioxidant activity according to our initial planning. The 
synthesized compounds 4a-f were tested for in vitro antioxidant activity by DPPH radical, hydroxyl radical and superoxide 
radical scavenging assays. The IC50 values of the standards and test samples are summarized in Table 3. In all three 
antioxidant assays, Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles derivatives 4c,4f bearing electron 
withdrawing groups on the phenyl ring showed antioxidant activities at 9.8 - 12.8 µM concentration. But, 4-Aryl-2-amino-6-
(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles derivative 4b and 4e with electron releasing fluore group and nitro 
phenyl ring showed good antioxidant activity (7.0 - 8.8 µM). Surprisingly, 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) 
pyridine-3-carbonitriles 4a without substitution on the phenyl ring is inactive in all antioxidant assays. Also, it should be 
noted that it is not possible to give any rational explanation for antioxidant activities even in the absence of essential enolic 
group.  
 
Table 3 IC50 values of 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 in anti-oxidant assays 
 
 
 
 
 
 
 
 
 
 
Compound 
Zone of inhibition in mm* 
Escherichia coli 
Klebsiella 
pneumoniae 
Salmonella typhi Shigella flexneri 
4a 12 11 12 11 
4b 12 - 21 23 
4c 12 - 26 15 
4d 15 12 23 22 
4e 14 12 21 20 
4f 13 11 20 19 
Compounds 
IC50 values in µM 
DPPH radical 
scavenging assay 
Hydroxy radical       
Scavenging assay 
Superoxide radical 
scavenging assay 
4a NA NA NA 
4b 12.4 12.8 9.8 
4c 11.1 11.0 12.7 
4d 11.2 11.2 11.8 
4e 11.1 11.0 11.5 
4f 11.0 10.8 11.4 
 
Ascorbic 
acid 
3.8 3.9 - 
Quercetin - - 4.9 
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Anti-inflammatory activity 
As per our objective, we next examined the anti-inflammatory activities of 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) 
pyridine-3-carbonitriles derivatives 4a-f by lipoxygenase inhibition and phospholipase A2 (PLA2) inhibition assays. The IC50 
values of the standards and test samples in both assays are given Table 4. In both the assays, 4-Aryl-2-amino-6-(4-
hydroxy coumarin-3-yl) pyridine-3-carbonitriles derivatives 4b and 4c bearing strong electron withdrawing nitro groups 
showed potent anti-inflammatory activity in lipoxygenase inhibition assay (5.0 – 5.1 µM) and PLA2 inhibition assay (26.5 - 
34.9 µM). While, the other derivatives substituted with weak deactivating (4b-e). Notably, compound 4a with no 
substitution on phenyl ring is not active. It should be noted that, 4b and 4c nearly have anti-inflammatory activities, as that 
of standards Indomethacin and Aristolochic acid. Thus, 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 
4 derivatives with strong deactivating groups are more potent than 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-
carbonitriles 4 derivatives with weak deactivating/activating groups .  
Table 4.  IC50 values of 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 for anti-inflammatory activity 
 
CONCLUSIONS 
In summary, we have synthesized a new 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 
derivatives and examined their antimicrobial, antioxidant and anti-inflammatory activities. The synthesized compounds 
showed moderate in vitro antibacterial activity. 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4 
derivatives are good antibacterial agents than the 4-Alkyl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 4  
derivatives. On contrary, in all the anti-oxidant assays, 4-Aryl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 
derivatives are poor antioxidants compared to 4-Alkyl-2-amino-6-(4-hydroxy coumarin-3-yl) pyridine-3-carbonitriles 
derivatives. Also, aryl derivatives bearing deactivating groups are less anti-oxidant properties than those bearing activating 
groups. But, it is not possible to give any explanation for the antioxidant activities of these compounds even in the absence 
of essential enolic group.  
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